Hewmun Lau

Inversor de Capital Privado en Broadview Ventures, Inc. .

Finance

Consumer Services

Health Technology

Perfil

Hewmun Lau is currently working as a Principal at Broadview Ventures, Inc. Prior to this, she worked as a Director at Merrimack Pharmaceuticals, Inc. from 2017 to 2019 and as a Senior Consultant at Navigant Consulting Group, Inc. from 2012 to 2015.
Ms. Lau has an MBA from Massachusetts Institute of Technology, an undergraduate degree from Brandeis University, and a graduate degree from Harvard Mit Health Sciences & Technology.

Cargos activos de Hewmun Lau

Empresas	Cargo	Inicio
Broadview Ventures, Inc. Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts.	Inversor de Capital Privado	01/05/2019

Todos los cargos activos de Hewmun Lau

Antiguos cargos conocidos de Hewmun Lau.

Empresas	Cargo	Fin
MERRIMACK PHARMACEUTICALS, INC.	Inversor de Capital Privado	31/03/2019
Navigant Consulting Group, Inc.	Consultor / Asesor	01/10/2015

Ver el detalle de la experiencia de Hewmun Lau.

Formación de Hewmun Lau.

Brandeis University	Undergraduate Degree
Harvard Mit Health Sciences & Technology	Graduate Degree
Massachusetts Institute of Technology	Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Hewmun Lau.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Broadview Ventures, Inc. Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts.	Finance
Merrimack Pharmaceuticals, Inc. Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.	Health Technology
Navigant Consulting Group, Inc.

Ver las conexiones de la empresa